miR-146a Expression Level as a Novel Putative Prognostic Marker for Acute Promyelocytic Leukemia

Figure 3

miR-146a expression and clinical characteristics of 32 patients. (a) miR-146a levels in APL patients, controls, and NB₄ cells. (b) miR-146a levels were positively correlated with white blood cell (WBC) counts. (c) miR-146a was positively correlated with PML/RARα gene expression. (d) miR-146a expression was negatively correlated with the Th/Ts ratio.

(a)

(b)

(c)

(d)